These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3166420)

  • 21. A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure.
    White LO; MacGowan AP; Lovering AM; Reeves DS; Mackay IG
    Drugs; 1987; 34 Suppl 1():56-61. PubMed ID: 3481329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and safety of single rising doses of ofloxacin in healthy volunteers.
    Marchbanks CR; Dudley MN; Flor S; Beals B
    Pharmacotherapy; 1992; 12(1):45-9. PubMed ID: 1549538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion of oral ofloxacin (HOE 280) into human prostatic tissue: assessment by an improved high-performance liquid chromatographic method.
    Claes R; Dusart Y; Dupont JC; Jeanbaptiste B; Podoor M; Douchamps J
    Infection; 1986; 14 Suppl 4():S263-5. PubMed ID: 3469159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
    Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-dose pharmacokinetics and dose proportionality of intravenous pazufloxacin mesilate in healthy Korean volunteers.
    Lee J; Seong SJ; Lim MS; Park SM; Park J; Seo JJ; Lee HW; Yoon YR
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):921-8. PubMed ID: 22809012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers.
    Walters T; Rinehart M; Krebs W; Holdbrook M
    Cornea; 2010 Mar; 29(3):263-8. PubMed ID: 20098307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ofloxacin in healthy subjects and patients with impaired renal function.
    Höffler D; Koeppe P
    Drugs; 1987; 34 Suppl 1():51-5. PubMed ID: 3125032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal tolerance of ofloxacin, a new gyrase inhibitor.
    Verho M; Dagrosa EE; Usinger P; Grötsch H; Malerczyk V; Uchida M; Rangoonwala R
    Pharmatherapeutica; 1985; 4(5):306-13. PubMed ID: 2866542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and relative bioavailability of ofloxacin tablets in 12 healthy volunteers.
    Diao Y; Li L; Zhou GH; Cheng Y
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):110-2. PubMed ID: 1598824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioequivalence evaluation of two different oral formulations of loperamide (Diarex Lactab vs Imodium capsules).
    Doser K; Meyer B; Nitsche V; Binkert-Graber P
    Int J Clin Pharmacol Ther; 1995 Aug; 33(8):431-6. PubMed ID: 8556221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ofloxacin in human serum, urine, and tear film after topical application.
    Borrmann L; Tang-Liu DD; Kann J; Nista J; Lin ET; Frank J
    Cornea; 1992 May; 11(3):226-30. PubMed ID: 1587130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers.
    Hasegawa T; Yamaki K; Nadai M; Muraoka I; Wang L; Takagi K; Nabeshima T
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):57-61. PubMed ID: 8004359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of ofloxacin from blood to sputum.
    Davies BI; Maesen FP; Geraedts WH; Baur C
    Drugs; 1987; 34 Suppl 1():26-32. PubMed ID: 3481324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg].
    Guibert J; Kitzis MD; Acar JF
    Pathol Biol (Paris); 1998 Oct; 46(8):656-60. PubMed ID: 9871938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
    Chulavatnatol S; Chindavijak B; Chierakul N; Klomsawat D
    J Med Assoc Thai; 2003 Aug; 86(8):781-8. PubMed ID: 12948278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary pharmacokinetic and clinical evaluation of ofloxacin in dental and oral cavity diseases.
    Pappalardo G; Bianchi A; Scire Scappuzzo G; Mirone M; Salomone S
    Int J Clin Pharmacol Res; 1989; 9(3):229-32. PubMed ID: 2663738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics, urinary excretion and plasma protein binding of ofloxacin in water buffalo calves (Bubalus bubalis).
    Ola AK; Sandhu HS; Dumka VK; Ranjan B
    J S Afr Vet Assoc; 2013 Apr; 84(1):E1-5. PubMed ID: 23718538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.